![Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. - Abstract - Europe PMC Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2828016/bin/bph0159-0502-f1.jpg)
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. - Abstract - Europe PMC
![PDF) DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR PRASUGREL HYDROCHLORIDE *Corresponding Author PDF) DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR PRASUGREL HYDROCHLORIDE *Corresponding Author](https://i1.rgstatic.net/publication/340340690_DEVELOPMENT_AND_VALIDATION_OF_STABILITY_INDICATING_RP-HPLC_METHOD_FOR_PRASUGREL_HYDROCHLORIDE_Corresponding_Author/links/5e84671a92851c2f5270fa06/largepreview.png)
PDF) DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR PRASUGREL HYDROCHLORIDE *Corresponding Author
![Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation](https://www.ahajournals.org/cms/asset/412b1e26-bf57-42c6-9619-80a6c4ad68af/14ff1.jpg)
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation
![PDF) Factors Coupled the Choice of Clopidogrel, Prasugrel And Ticagrelor in Patients Undergoing Percutaneous Coronary Intervention PDF) Factors Coupled the Choice of Clopidogrel, Prasugrel And Ticagrelor in Patients Undergoing Percutaneous Coronary Intervention](https://www.researchgate.net/profile/Kiron-Ss-2/publication/338187429/figure/fig3/AS:840581987196928@1577421771203/Figure-4-Drug-use-in-CAD-DVD-was-diagnosed-in-135-patients-of-these-62-459-were_Q320.jpg)